Assessing quality of life in Behçet's disease: a systematic review.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 18 02 2022
accepted: 26 05 2022
entrez: 15 9 2022
pubmed: 16 9 2022
medline: 17 9 2022
Statut: ppublish

Résumé

The assessment of quality of life (QoL) in Behçet's disease (BD) patients has been a surrogate of disease outcomes, but a wider impact on the patient's lifestyle has not been considered. This systematic review aims to provide an overview of the existing tools specifically adopted to explore the QoL in BD patients. A systematic literature review was conducted using 2 electronic databases, according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. A combination of BD and QoL-related search terms were used. All articles were screened by 3 independent reviewers for title, abstract and full text level. Studies investigating QoL in BD patients were included. 64 papers of 497 records were retained. Data about 7,449 patients with a BD diagnosis and QoL evaluation were collected. 47 different tools to evaluate QoL were detected. The mean number of tools adopted in each study was 2.14±1.34. General QoL and psychological and social impact were investigated in 68.75% and 54.69% respectively. The correlation with disease activity was investigated in 71.86%. The assessment of QoL in BD patients may provide a fundamental measurement for health to evaluate the outcome of interventions for BD patients. The adoption of a single validated QoL tool, developed including the BD patient's perspective, may provide an accurate and effective assessment, ensure the comparison within different cohorts, and set standardised values to define QoL level in BD patients.

Identifiants

pubmed: 36106544
pii: 18453
doi: 10.55563/clinexprheumatol/sian1b
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1560-1566

Auteurs

Maria Vincenza Mastrolia (MV)

Rheumatology Unit, Meyer Children's University Hospital, Firenze, Italy. maria.mastrolia@unifi.it.

Diana Marinello (D)

Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Federica Di Cianni (F)

Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Rosaria Talarico (R)

Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Gabriele Simonini (G)

Rheumatology Unit, Meyer Children's University Hospital, NEUROFARBA Department, University of Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH